FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Meda

BioPhausia focuses and sells OTC products to Meda for SEK 190 million

28-Sep-2010 - BioPhausia signed an agreement to sell its portfolio of OTC products to Meda for a total of SEK 190 million, plus the value of the inventory. The Company has also completed the previously communicated strategic review of its generics portfolio, allowing further concentration on prescription ...

flow generics Pharmaceutics +1

Meda acquires Alaven, a US specialty pharma company

01-Sep-2010 - Meda has signed an agreement to acquire the US specialty pharmaceutical company Alaven. The acquisition will significantly enhance Meda’s marketing capabilities in the US and expand the therapeutic focus to include both gastroenterology and women’s health; areas that Meda already operates in ...

bases distal ulcerative colitis gastric ulcer +4

Meda: Onsolis receives FDA approval

21-Jul-2009 - The U.S. Food and Drug Administration (FDA) has approved Onsolis (fentanyl buccal soluble film). This new and patented product is indicated for the management of breakthrough pain in cancer patients who are already receiving and who are tolerant to opioid therapy for their underlying persistent ...

cancer pain food membranes +2

Valeant Pharmaceuticals Completes Sale of Certain European Operations to Meda AB

16-Sep-2008 - Valeant Pharmaceuticals International announced that it has completed its sale of certain business operations located in Western Europe, Eastern Europe, and certain export markets to Meda AB, pursuant to the Acquisition Agreement entered into by Meda and Valeant on August 4, 2008. Valeant ...